Hayley J Hawkins MD

PubMed

• A novel genetic variant associated with progressive familial intrahepatic cholestasis type 3: A case series.
  Brooke P Quertermous, Hayley J Hawkins, Alyssa A Schlotman, Huiying Wang, Sarah Kemme
  JPGN Reports. 2024-11-01
• 2 citations
  Examination of Wnt signaling as a therapeutic target for pancreatic ductal adenocarcinoma (PDAC) using a pancreatic tumor organoid library (PTOL).
  Hayley J Hawkins, Betelehem W Yacob, Monica E Brown, Brandon R Goldstein, John J Arcaroli
  Plos One. 2024-01-01

Abstracts/Posters

• Clinical Utilization and Outcomes of Hypomethylating Agents and Venetoclax in Patients with Myelodysplastic Syndrome - a Multicenter Retrospective Analysis
  Guru Subramanian Guru Murthy, Somedeb Ball, Jonathan Feld, Ramzi Abboud, Michael Haddadin, Shyam Ajay Patel, Ashwin Kishtagari, Hayley Hawkins, Veronica Guerra, Emily ..., ASH
• Clinical Outcomes and Variability Based on Baseline Cytogenetic Risk of Patients with MDS Treated with Hypomethylating Agents: An Analysis from the International Conso...
  Ted M. Getz, MD1, Tariq Kewan, MD2, Jan Philipp Bewersdorf, MD3,4, Jessica M. Stempel, MD2, Luca Lanino, MD5, Wei Wei, MD, PhD6, Najla H. Al Ali, Ms7*, Amy E. DeZern, ..., ASH
• Impact of Type of Hypomethylating Agent (HMA) Used on Outcomes of Patients (Pts) with Higher-Risk Myelodysplastic Syndromes/Neoplasms (HR-MDS) - a Large, Multicenter, ...
  Jan Philipp Bewersdorf, Tariq Kewan, Ondrej Blaha, Maximilian Stahl, Najla H Al Ali, Amy E. DeZern, Mikkael A. Sekeres, Geoffrey L Uy, Hetty E. Carraway, Pinkal Desai,..., ASH
• Impact of Response to Hypomethylating Agent-Based Therapy on Survival Outcomes in the Context of Baseline Clinical-Molecular Risk and Transplant Status in Patients wit...
  Benjamin Rolles, MD1,2, Jan Philipp Bewersdorf, MD3,4, Tariq Kewan, MD5, Ondrej Blaha, PhD6*, Jessica M. Stempel, MD3, Luca Lanino, MD7, Najla H. Al Ali, Ms8*, Amy E. ..., ASH
• Join now to see all